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Abstract 
Background: Obesity may establish a crucial barrier for effective fertility treatment 
in polycystic ovary syndrome (PCOS) females. 
Objective: To compare results of intra-cytoplasmic sperm injection (ICSI) in 
females with and without polycystic ovarian syndrome and further appraise the 
effect of obesity in PCOS females. 
Materials and Methods: A cross-sectional study from June 2015 to July 2016 
included non-PCOS and PCOS (recognized by Rotterdam criteria) females who 
underwent ICSI. The PCOS were further stratified into non-obese and Obese 
according to the South Asian criteria for body mass index. Results were categorized 
on the basis of beta-human chorionic gonadotropin (β-hCG) and transvaginal scan 
into non-pregnant (β-hCG <25 mIU/ml), preclinical abortion (β-hCG >25 mIU/ml 
with no fetal cardiac activity) and clinical pregnancy (β-hCG >25 mIU/ml with fetal 
cardiac activity on transvaginal scan). In addition, reproductive outcomes; 
implantation rate, clinical pregnancy rate and miscarriage rate among obese and 
non-obese PCOS and non-PCOS patients were compared. 
Results: Our results revealed 38.5% clinical pregnancy rate in non-PCOs females, 
23.8% in non-obese PCOS females whereas 26.4% in obese PCOS. Preclinical 
abortions were found to be highest (31.5%) in non-obese PCOS females and were 
the lowest (26.2%) in non-PCOS females. In non-PCOS group and non-obese PCOS 
females 35.4% and 44.6%, respectively, failed to become pregnant. 
Conclusion: The success after ICSI in terms of number of clinical pregnancies was 
more in non-PCOS patients as compared to PCOS. Increase in body mass index 
reflected a negative impact on the reproductive outcome in PCOS patients. 
 
Key words: Quetelet’s index, Obesity, Polycystic ovary syndrome, Sperm injection, 
Intracytoplasmic, Infertility. 
 
Introduction 
 
olycystic ovary syndrome (PCOS) is 
found in 6-10% of the general 
population and considered to be a 
common hormonal disorder in females of 
reproductive age (1). According to the 
Rotterdam criteria, females suffering from 
PCOS have decreased or no ovulation, 
excessive androgen secretion and ultrasound 
evidence of poly cystic ovaries (2). More than 
10 follicles, encircling an echo-dense stroma, 
measuring 2-8 mm in diameters, contained in 
an ovary sizing more than 10 CC in volume is 
diagnostic of PCOS on ultrasound. PCOS is 
manifested as changes in hormonal, 
reproductive and metabolic functions. 
Reproductive and hormonal disorders of 
PCOS include hypergonadism, anovulation, 
and increased secretion of Luteinizing 
hormone (LH) and early miscarriage risk. 
Metabolic disorders of PCOS include 
hyperinsulinemia, type 2 diabetes, obesity and 
hyperlipidemia. PCOS hormonal imbalances 
leading to anovulation is a significant cause of 
infertility (2).  
Primary infertility is found to be highly 
prevalent in South Asia, particularly in 
Pakistan with an estimated rate of 3% while 
secondary infertility in Pakistan is 18.4% 
Infertility, specifically associated with 
anovulation, is initially treated with anti-
estrogen clomiphene citrate and exogenous 
gonadotropins. Unfortunately, this can 
increase the risk of multiple pregnancy rates, 
therefore many patients are given assisted 
P 
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reproductive treatment (ART) comprising of in 
vitro fertilization (IVF) and intra-cytoplasmic 
sperm injection (ICSI) (3). ICSI is a highly 
developed micromanipulation technique in 
which a single sperm is injected into an egg in 
vitro using micro-injectors (4). Obesity may 
establish a crucial barrier for effective fertility 
treatment in females who are PCOS. The 
relationship of PCOS and ICSI outcome has 
been the subject of observational studies. 
Obese females with PCOS had less number 
of retrieved oocytes and clinical pregnancy 
rates with a higher rate of abortions (5). In 
contrast, some studies suggested that obese 
and non-obese PCOS patients revealed no 
significant differences in IVF/ICSI results (6).  
This study aimed to assess the ICSI 
outcome in obese and non-obese women with 
PCOS by comparing the number of retrieved 
oocytes, implantation rate, clinical pregnancy 
rate and miscarriage rates.  
 
Materials and methods 
 
A cross sectional study was conducted 
from June 2015 till July 2016. The sample size 
was calculated in Open Epi software version 3 
based on the formula; n= [DEFF*Np(1-p)]/ 
[(d2/Z21-α/2*(N-1) +p*(1-p)]. We required a 
sample size of 246 patients in order to 
achieve a confidence interval of 95% with a 
20% prevalence of PCOS. Despite the sample 
size being 246, we surveyed 286 females to 
cover the drop-outs which can occur during 
the course of treatment. PCOS group was 
further classified into Non-Obese PCOS (body 
mass index (BMI <25 kg/m2, 130 females) and 
91 females in Obese PCOS group (BMI ≥25 
kg/m2).  
The clinical examinations monitored 
principles of Declaration of Helsinki. Females 
with primary infertility for at least for 2 yr, age 
range 20-40 yr and normal uterine cavity 
assessed on ultrasound, hysterosalpingogram 
or hysteroscopy were included. The first fresh 
IVF-embryo transfer cycle with long down 
regulation protocol was taken into 
consideration. Exclusion criteria consisted of 
females with known metabolic disorders 
(Diabetes, Hypertension, Metabolic 
Syndrome), pelvic pathologies 
(hydrosalpinges, myoma etc.), presence of 
stage IV (severe) endometriosis, and past 
history of myomectomy. All the cases that 
developed hyper stimulation were not included 
irrespective of the fact that cycle was 
canceled or not. PCOS was diagnosed by 
Rotterdam criteria; females who had 
decreased or no ovulation, excessive 
androgen secretion and ultrasound evidence 
of PCO were selected (2).  
The baseline investigations included 
measurement of BMI on the basis of South 
Asian Criteria (normal weight: 18.0-22.9 
kg/m2, overweight: 23.0-24.9 kg/m2, obese: 
≥25.0 kg/m2) (7); day 3 follicle stimulating 
hormone (FSH) and antral follicle count done 
by transvaginal scan (TVS). The treatment 
protocol of females from down regulation, 
controlled ovarian stimulation, ovulation 
induction (OI), oocyte pick up and embryo 
transfer was carried out as mentioned (8). The 
preovulatory follicle count (PFC) and 
endometrial thickness were measured on OI 
day. On the basis of beta-human chorionic 
gonadotropin (β-hCG) done 2 wk after egg 
collection and TVS performed after another 2 
wk after identification of clinical pregnancy 
from pre-clinical abortion. 
On the basis of β-hCG and TVS, results 
were categorized into non-pregnant with β-
hCG <25 mIU/ml and preclinical abortion β-
hCG >25 mIU/ml with no fetal cardiac activity 
on TVS. Clinical pregnancy was identified by 
the existence of a gestational sac with cardiac 
movement perceived by TVS. Oocyte 
recovery rate was number of oocytes obtained 
in comparison with visible follicles on TVS (9). 
Fertilization rate was determined by formation 
of pronuclei from the microinjected oocytes. 
The implantation rate was determined by 
appearance gestational sacs on TVS with 
respect to number of transferred embryos 
(10). A pregnancy rate was estimated by 
existence of an intrauterine gestational sac on 
TVS; per number of patients in the cycle (9). 
 
Ethical consideration 
Ethical approval was obtained from the 
Institutional Review Board of Islamabad Clinic 
Serving Infertile Couples (256-ICSFC-REC-
16). Informed written consent was obtained 
from every participant.  
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Statistical analysis 
Computational data was stored and 
analyzed by employing SPSS software 
(Statistical Package for the Social Sciences, 
version 21.0, SPSS Inc., Chicago, IL, USA). 
Quantitative variables were computed for 
Mean±SD. Analysis of Variance (ANOVA) with 
Tukey’s HSD test was applied for post-hoc 
analysis, and significance at p-value of 0.05. 
 
Results 
 
Out of an aggregate of 286 infertile females 
undergoing ICSI procedure included in data 
analysis, 65 (22.7%) were normal females 
(non-PCOS group) and 221 (77.3%) were 
PCOS females. Of the 221 PCOS females, 
130 were included in non-obese PCOS group 
(BMI <25) and 91 females were included in 
obese PCOS group (BMI ≥25). Mean±SD of 
oocyte parameters of the 3 groups are 
summarized in Table I. The three groups did 
not differ with regards to age. PFC and 
number of oocytes/patient were found to be 
higher in obese PCOS group. The quality of 
embryos was graded as good (Grade I), fair 
(Grade II) and poor (Grade III) on the basis of 
cleavage rate and differentiation before 
embryo replacement. Good quality embryo 
with blastomeres of same size, slight or no 
fragmentation, and a zona pellucida that is not 
enormously dense in appearance; fair with 
blastomeres of same size, little fragments in 
cytoplasm wrapping <10% of embryo. Poor 
quality embryo had blastomeres of noticeably 
uneven size and moderate-to-significant 
fragments of cytoplasm, wrapping >10% of 
embryo external (11)  
The number of fertilized oocytes, number of 
cleaved embryos and grade 1 embryos were 
more in non-PCOS group as compared to 
non-PCOS group (Table I). Endometrial 
thickness did not differ widely among the three 
groups. Basal progesterone was significantly 
low (9.69±3.66 ng/ml) in non-obese PCOS 
females. Progesterone on OI day and 
estradiol on day of ovulation were found to be 
lower in non-obese PCOS females. 
Table II compares the reproductive 
outcomes in the three groups. Fertilization 
rate and cleavage rate were the lowest in 
obese PCOS females and were the highest in 
non-PCOS females. Implantation rate was 
significantly high (62.31±32.31) in non-PCOS 
group compared to obese PCOS 
(26.37±38.01) and non-obese PCOS group 
(23.46±39.79). 
Table III compares the pregnancy 
outcomes among the three groups. 38.5% of 
the non-PCOS females achieved clinical 
pregnancies whereas only 23.8% non-obese 
PCOS females achieved clinical pregnancies. 
Similarly, preclinical abortions were found to 
be highest (31.5%) in non-obese PCOS 
females and were the lowest (26.2%) in non-
PCOS females. 44.6% non-obese PCOS 
females never got pregnant while only 35.4% 
non-PCOS females failed to get pregnant. 
 
 
 
Table I. Comparison of characteristics of study groups 
Variables 
PCOS (n= 221) 
Non-PCOS (n=65) p-value 
Obese (n=91) Non-Obese (n=130) 
Female age (yr)  32.02 ± 4.81 32.42 ± 4.45 31.34 ± 4.63 0.302 
Pre-ovulatory follicle count  10.86 ± 1.66 9.28 ± 1.57 8 ± 1.61*^ <0.001 
No of oocytes/patient 9.86 ± 1.66 8.45 ± 1.71 7.86 ± 1.54*^ <0.001 
No of oocytes Metaphase II 6.71 ± 1.09 7.07 ± 1.62 7.52 ± 1.64^ 0.004 
No of oocytes fertilized 4.35 ± 1.03 4.88 ± 1.33 6.03 ± 1.55*^ <0.001 
No of cleaved embryos 3.89 ± 1.3 4.45 ± 1.5 5.68 ± 1.53*^ <0.001 
Grade_1 0.99 ± 0.1 1.59 ± 0.49 2.71 ± 0.76*^ <0.001 
Grade_2 1.9 ± 0.34 1.95 ± 0.57 1.68 ± 0.56*^ 0.001 
Grade_3 1.65 ± 0.77 1.32 ± 0.47 0.74 ± 0.54*^ <0.001 
Endometrial thickness (mm) 8.8 ± 3.2 8.05 ± 3.24 8.14 ± 3.63 0.231 
Basal progesterone (ng/ml) 14.17 ± 7.65 9.69 ± 3.66 14.3 ± 9.39* <0.001 
Progesterone on ovulation induction day (ng/ml) 1.64 ± 0.74 1.46 ± 0.76 1.55 ± 0.68*^ 0.220 
Progesterone on embryo transfer day (ng/ml) 146.43 ± 63.51 154.37 ± 58.95 137.62±64.11*^ 0.195 
Estradiol on ovulation induction day (pg/ml) 2342.71±243.0 2139.43±411.7 2267.2±243.6^ <0.001 
Estradiol on embryo transfer day (pg/ml) 891.27±119.39 856.07±173.86 881 ± 115.54^ 0.188 
Data presents values as Mean±SD.  
ANOVA test was applied to calculate difference between groups and p <0.001 was considered significant.  
PCOS: Polycystic ovary syndrome  
*p value <0.05, non PCOS with non-obese PCOS 
^ p value <0.05, non PCOS with obese PCOS 
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Table II. Comparison of reproductive outcome in PCOS and non-PCOS 
Rates 
PCOS (n= 221) 
Non PCOS (n=65) p-value 
Obese (n=91) Non-Obese (n=130) 
Oocytes retrieval rate 90.58 ± 1.38 90.7 ± 4.43 98.54 ± 4.78*^ <0.001 
Oocyte maturity rate  69.059 83.800 95.504*^ <0.001 
Fertilization rate  64.64 ± 10.05 68.17 ± 5.62 79.61 ± 10.59*^ <0.001 
Cleavage rate 87.67 ± 16.55 91.26 ± 17.72 94.42 ± 7.68*^ 0.028 
Implantation rate 26.37 ± 38.01 23.46 ± 39.79 62.31 ± 32.31*^ <0.001 
Data presents values as frequencies in percentages using the following formulas.  
Oocyte retrieval rate= Number of Oocytes/ PFC ×100 (PFC: preovulatory follicle count) 
Oocyte Maturity rate= Number of mature oocytes=Mature oocytes/ number of oocytes ×100 
Fertilization rate= Pronuclei/ mature oocytes ×100 
Cleavage rate= Cleaved embryo/ fertilized embryo ×100 
Impanation rate= Number of sacs/ number of embryos transferred×100  
*p value <0.05, non PCOS with non-obese PCOS 
^ p value <0.05, non PCOS with obese PCOS 
 
Table III: Outcome after ICSI in study Groups 
Pregnancy 
PCOS (n= 221) 
Non-PCOS (n= 65) 
Non-Obese (n= 130) Obese (n= 91) 
Not pregnant 42.9 44.6 35.4*^ 
Preclinical abortion 30.8 31.5 26.2*^ 
Clinical pregnancies 26.4 23.8 38.5*^ 
Data presented as percentage. 
PCOS: Polycystic ovary syndrome 
*p value <0.05, non PCOS with non-obese PCOS 
^ p value <0.05, non PCOS with obese PCOS 
 
Discussion 
 
Results of current research revealed that 
clinical pregnancies rate was highest in non-
PCOS females followed by non-obese PCOS 
and then obese PCOS. Similarly, preclinical 
abortions were found to be maximum in non-
obese PCOS females and lowest in non-
PCOS females. Around 44.6% non-obese 
PCOS females never got pregnant while only 
35.4 % non-PCOS females failed to get 
pregnant in the study. Although the effect of 
BMI on IVF/ICSI outcomes remain 
controversial due to different inclusion criteria 
and the cutoff point of BMI yet we discovered 
that increase in BMI effected the pregnancy 
outcome in PCOS patients.  
PCOS females experiencing fertility 
management have a much higher possibility 
of multiple pregnancies and other adverse 
complications as a result of ovarian 
hyperstimulation. Due to the failure of less 
invasive techniques, IVF/ICSI is deliberated 
as best treatment choice intended to restore 
fertility whereas minimizing the chance of 
multiple gestations. The association of obesity 
with PCOs has been observed in 30-75% of 
females (12). Recent data proposes that, 
irrespective of PCOS, pregnancy attainment 
and preservation is poorly pretentious by an 
increase in BMI. Obese women thus 
experience lesser options of clinical 
pregnancy with an increased miscarriage rate 
after getting infertility management. In our 
study, we found that PFC was higher in PCOS 
groups and lower in non-PCOS group. This is 
attributed to hormonal disturbances in PCOS 
females resulting in the development of 
multiple small follicles that do not ovulate each 
month. Others have previously reported 
similar results (13).  
Ciepiela and coworkers also found that the 
number of follicles, as well as oocytes, was 
higher in PCOS group even at a lower dose of 
gonadotropins (14). Number of oocyte per 
patient was found to be higher in PCOS 
groups and lower in non-PCOS group 
confirming previous studies. It has been 
observed that obesity, as well as presence of 
PCOS, results in reduction in size of oocytes 
(15, 16). Increased number of MII oocytes is 
associated with positive ICSI outcomes (8). 
MII oocytes were found to be the highest in 
non-PCOS group in our study. Similar results 
were found in previous studies (15). 
Some studies have shown higher number 
of MII oocytes in PCOS females but this was 
mainly due to the fact that PCOS females 
develop greater number of oocytes. In these 
studies, percentage of MII oocytes was still 
higher in non-PCOS females (14). Our results 
showed a negative association is existed 
between MII oocytes with BMI supported by 
others (13). Number of fertilized oocytes was 
found to be lowest in obese PCOS group and 
lower in non-Obese PCOS group. In contrast, 
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other studies showed increased number of 
oocytes were fertilized in PCOS females (14). 
However, Hind and colleagues  proposed that 
BMI and PCOS have no significant effect on 
the number of oocytes fertilized (17). There is 
an increased incidence of pregnancy loss in 
PCOS as a result of the inborn endocrine 
disruption linked to the syndrome (18).  
Our results revealed that rate of clinical 
pregnancy in non-PCOS females was 38.5% 
whereas it was 23.8% in non-Obese PCOS 
females. Similarly, preclinical abortions were 
found to be highest (31.5%) in Obese PCOS 
females and were the lowest (26.2%) in non-
PCOS females. Our data revealed that the 
clinical pregnancy rate in non-PCOS females 
was higher whereas failure of pregnancy was 
highest in Obese PCOS females. The 
negative impact of increase in weight on the 
quality of oocyte without PCOS has been 
documented by a decrease in number of 
transferable embryos in obese, females. A 
subgroup enquiry discovered smaller oocytes 
in the obese control patients compared to the 
non-obese control infertile patients proposing 
that obesity affects oocyte size independent of 
PCOS. (15) Our results demonstrated that 
preclinical abortions were found to be highest 
(31.5%) in obese PCOS females and were the 
lowest (26.2%) in non-PCOS females. Some 
scientists concluded in their study that, the 
presence of PCOS in non-obese patient may 
be a favorable prognostic factor before 
considering IVF (14).  
Wang and colleagues emphasized that in 
young PCOS females (less than 25 yr of age) 
BMI should be reduced to 26 kg/m2 before 
initiation of ART (16, 19). Overweight and 
obese PCOS patients should thus be 
encouraged to lose weight before initiation of 
ART (6). It was observed that BMI impaired 
endometrial receptivity in assisted 
reproductive treatment protocols (16, 20) 
Higher implantation and pregnancy rates were 
acquired with an endometrial thickness of 7-8 
mm in our population (21). However, we did 
not observe any significant difference in 
endometrial thickness in PCOS and non-
PCOS to impact on pregnancy outcome. 
Okohue observed likelihood of becoming 
pregnant with endometrial thickness 8-14 mm 
(22). The number of clinical pregnancies 
acquired after ICSI was high in non-PCOS 
patients as compared to PCOS. Increase in 
BMI of PCOS exerted a dual effect, decreased 
the number of clinical pregnancies and 
enhanced the number of non-conceptions and 
pre-clinical abortions. Our study did not 
exclude the females who had infertility 
because of male factor, since we wanted to 
compare results of ICSI in females with and 
without PCOS, hence impact of severe male 
factor on IVF outcome could not be excluded 
which is a limitation. Thus it is recommended 
to induce weight reduction strategies for 
PCOS patients before initiation of ART for 
enhancing the results of IVF/ICSI. 
The success after ICSI in terms of number 
of clinical pregnancies was more in non-
PCOS patients as compared to PCOS. 
Increase in body mass index reflected a 
negative impact on the reproductive outcome 
in PCOS patients. Since PCOS is mostly 
occurred with obesity, it is essential to 
decrease weight in PCOS patients for 
attainment of improved outcomes of IVF/ICSI. 
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